SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-144977
Filing Date
2022-05-09
Accepted
2022-05-09 16:06:29
Documents
4
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A d325898ddef14a.htm DEF 14A 367209
2 GRAPHIC g325898g00m01.jpg GRAPHIC 288593
3 GRAPHIC g325898g00m02.jpg GRAPHIC 126879
4 GRAPHIC g325898g00r01.jpg GRAPHIC 42636
  Complete submission text file 0001193125-22-144977.txt   987636
Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Filer) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39802 | Film No.: 22904887
SIC: 2836 Biological Products, (No Diagnostic Substances)